ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,010Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 1454

$1.11M Total Retail Price of All Prescriptions

Rank: 60 out of 1454

869 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 869 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

21% of this provider’s 869 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 20,546 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
HYDROCODONE-ACETAMINOPHEN 1,123 867 S3 1 7
FUROSEMIDE 1,109 933 2 6
SIMVASTATIN 1,048 895 3 1
OMEPRAZOLE 981 786 4 3
LEVOTHYROXINE SODIUM 824 739 5 5
CITALOPRAM HBR 665 606 6 21
METOPROLOL TARTRATE 582 506 7 10
AMLODIPINE BESYLATE 566 520 8 2
LISINOPRIL 562 481 9 4
WARFARIN SODIUM 539 473 10 17
DONEPEZIL HCL 457 450 11 29
GABAPENTIN 455 298 12 16
POTASSIUM CHLORIDE 439 347 13 15
PREDNISONE 388 337 14 36
QUETIAPINE FUMARATE 372 304 15 91
LOSARTAN POTASSIUM 310 272 16 14
RANITIDINE HCL 306 249 17 43
CARVEDILOL 301 252 18 24
ZOLPIDEM TARTRATE 286 207 19 19
METFORMIN HCL 285 224 20 8
CEPHALEXIN 243 198 21 127
SERTRALINE HCL 237 172 22 26
CIPROFLOXACIN HCL 224 170 23 64
NAMENDA 215 213 24 48
MIRTAZAPINE 212 171 25 53
DIVALPROEX SODIUM 202 145 26 106
TRAMADOL HCL 200 169 27 20
ALLOPURINOL 198 172 28 28
MELOXICAM 194 153 29 37
TAMSULOSIN HCL 193 152 30 34
LEVETIRACETAM 189 118 31 114
LANTUS 187 111 32 51
CLOPIDOGREL 173 160 33 32
PROMETHAZINE HCL 171 112 R 34 82
LOVASTATIN 164 121 35 39
AZITHROMYCIN 161 132 36 42
METOPROLOL SUCCINATE 158 126 37 13
POLYETHYLENE GLYCOL 3350 150 130 38 61
FENTANYL 148 59 S2 39 104
PRAVASTATIN SODIUM 143 97 40 12
LOSARTAN-HYDROCHLOROTHIAZIDE 143 123 40 38
GLIPIZIDE 139 118 42 62
CEFUROXIME 139 112 42 150
VENLAFAXINE HCL ER 138 98 44 105
ATENOLOL 138 131 44 18
SEROQUEL 138 108 44 177
RISPERIDONE 136 103 47 86
TRAZODONE HCL 131 57 48 50
TRIAMTERENE-HCTZ 126 125 49 44
SPIRONOLACTONE 126 98 49 63
FLUTICASONE PROPIONATE 124 98 51 30
LEVEMIR 120 104 52 202
FLUCONAZOLE 119 90 53 160
CYMBALTA 116 88 54 55
DILTIAZEM 24HR CD 114 110 55 76
TRIAMTERENE-HYDROCHLOROTHIAZID 113 83 56 168
NOVOLIN R 112 66 57 180
PLAVIX 112 101 57 45
CLONIDINE HCL 111 73 59 49
NYSTOP 108 73 60 245
SYNTHROID 107 88 61 25
GLIMEPIRIDE 107 95 61 33
LISINOPRIL-HYDROCHLOROTHIAZIDE 102 83 63 27
NOVOLOG 102 75 63 99
ALBUTEROL SULFATE 99 86 65 178
HYDROCHLOROTHIAZIDE 99 87 65 9
SULFAMETHOXAZOLE-TRIMETHOPRIM 99 68 65 108
CYCLOBENZAPRINE HCL 97 66 R 68 59
ISOSORBIDE MONONITRATE ER 94 87 69 46
VENLAFAXINE HCL 92 76 70 229
CARBIDOPA-LEVODOPA 88 85 71 130
METOCLOPRAMIDE HCL 87 68 72 121
LEVOXYL 86 86 73 84
KLOR-CON M20 85 60 74 54
DIGOXIN 84 79 75 70
BACLOFEN 82 18 76 146
DIPHENOXYLATE-ATROPINE 80 68 77 328
FLUOXETINE HCL 80 61 77 72
TRIAMCINOLONE ACETONIDE 80 74 77 142
AMITRIPTYLINE HCL 79 64 R 80 71
NYSTATIN 74 53 81 184
DIOVAN 73 52 82 40
MECLIZINE HCL 73 64 82 132
PHENYTOIN SODIUM EXTENDED 72 33 84 138
OXYCODONE HCL 71 48 S2 85 80
PAROXETINE HCL 70 48 86 73
NOVOLIN N 70 50 86 261
FINASTERIDE 66 37 88 94
OXYCODONE HCL-ACETAMINOPHEN 65 51 S2 89 93
DILTIAZEM 24HR ER 63 57 90 120
OXYBUTYNIN CHLORIDE ER 63 45 90 156
TRAVATAN Z 63 52 90 218
DICLOFENAC SODIUM 61 46 93 118
OXYBUTYNIN CHLORIDE 61 40 93 169
DILTIAZEM ER 61 34 93 126
SYMBICORT 59 40 96 143
BENAZEPRIL HCL 58 58 97 57
TOPIRAMATE 57 0 98 192
ALENDRONATE SODIUM 56 50 99 35
PROAIR HFA 56 27 99 56
IBUPROFEN 56 31 99 107
LANTUS SOLOSTAR 56 38 99 79
NEXIUM 54 54 103 23
ROPINIROLE HCL 54 20 103 96
CELEBREX 53 53 105 81
KLOR-CON M10 52 49 106 145
VENTOLIN HFA 52 30 106 112
GLYBURIDE-METFORMIN HCL 52 42 R 106 139
DOXYCYCLINE HYCLATE 51 47 109 110
HYDRALAZINE HCL 50 17 110 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 23, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.